News
ASCO 2025: IL-15RαFc Superagonist SHR-1501 with or Without Bacille Calmette Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: A Phase 1/2 Study (UroToday.com) The 2025 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback